Iván D Vélez MD PhD

Malaria

0,0

2,5

5,0

7,5

10,0

12,5

15,0

59 61 63 65 67 69 71 73 75 77 79 81 83 85 87 89 91 93 95 97 99 01 03

AÑO

ÍND

ICE

PA

RA

SIT

AR

IO A

NU

AL

(Ca

so

s x

10

00

ha

bit

an

tes

)

ROL OF INVESTIGATORS

Politicians, Health authorities Pharmaceutical industry

Pipeline and deliver products for Tropical diseases

multidisciplinary approach : biological, social and health sciences working together

CIDEPRO: Public-Private alliance

• No high indicators of research…. Papers, patents… but capacity … interest in scientist … •The “ spirit” of CIDEPRO: Social use of product development

•Industry: no big profit but no lost …

•Patents as indicator of success… credibility… ???? rethinking

• No high indicators of research…. Papers, patents… but capacity … interest in scientist … •The “ spirit” of CIDEPRO: Social use of product development

•Industry: no big profit but no lost …

•Patents as indicator of success… credibility… ???? rethinking

Colombian reality

Scientific committee

I+D+I Committee

Source of fundings

National department of science and technology

Universities International sponsors

S

O

O2N

S

O

S

O

OO

S

OAc

S

O

O

O

S

OH

O

O

O2N

O

O

S

O

O

O

O

NO2

O

OH

S

OH

OO

S

O

S

O

O

S

O

OO

S

O

O O

O

OAc

SO

OH

SO

OH

Help to solve problems:Thermotherapy for CL…..New, cheaper deviseLocal treatments for CL…… clinical evaluation of new compoundsArtemisa annua infusion: international collaborative project with LuxembourgMollusquicide for Fasciola hepatica controlGeneric antimalarials produced at the University drugs plants for Humaxph… cheaper

Innovation

The international standards for preclinical and clinical phases : expensive

We need develop capacity in some preclinical areas: toxicity in animal models…

PROBLEMS